Disease correction the iPSC way: Advances in iPSC-based therapy

I. Sancho-Martinez; M. Li; J. C. Izpisua Belmonte

doi:10.1038/clpt.2010.341

Disease correction the iPSC way: Advances in iPSC-based therapy

I. Sancho-Martinez, M. Li, J. C. Izpisua Belmonte

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

Pluripotent stem cells possess the capacity for self-renewal and the ability to differentiate into all cell types of the three embryonic germ layers. Accordingly, given their potential use in regenerative medicine, they have long attracted the attention of researchers. Embryonic stem cells (ESCs) represent the model pluripotent stem cell population. However, the use of ESCs in regenerative therapies faces major hurdles-namely, immune rejection and the necessity to use early-stage embryos for ESC isolation.

Original language	English (US)
Pages (from-to)	746-749
Number of pages	4
Journal	Clinical Pharmacology and Therapeutics
Volume	89
Issue number	5
DOIs	https://doi.org/10.1038/clpt.2010.341
State	Published - May 2011
Externally published	Yes

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1038/clpt.2010.341

Cite this

@article{0d98c69660d945f79c49d32932791daa,

title = "Disease correction the iPSC way: Advances in iPSC-based therapy",

abstract = "Pluripotent stem cells possess the capacity for self-renewal and the ability to differentiate into all cell types of the three embryonic germ layers. Accordingly, given their potential use in regenerative medicine, they have long attracted the attention of researchers. Embryonic stem cells (ESCs) represent the model pluripotent stem cell population. However, the use of ESCs in regenerative therapies faces major hurdles-namely, immune rejection and the necessity to use early-stage embryos for ESC isolation.",

author = "I. Sancho-Martinez and M. Li and {Izpisua Belmonte}, {J. C.}",

year = "2011",

month = may,

doi = "10.1038/clpt.2010.341",

language = "English (US)",

volume = "89",

pages = "746--749",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Disease correction the iPSC way

T2 - Advances in iPSC-based therapy

AU - Sancho-Martinez, I.

AU - Li, M.

AU - Izpisua Belmonte, J. C.

PY - 2011/5

Y1 - 2011/5

N2 - Pluripotent stem cells possess the capacity for self-renewal and the ability to differentiate into all cell types of the three embryonic germ layers. Accordingly, given their potential use in regenerative medicine, they have long attracted the attention of researchers. Embryonic stem cells (ESCs) represent the model pluripotent stem cell population. However, the use of ESCs in regenerative therapies faces major hurdles-namely, immune rejection and the necessity to use early-stage embryos for ESC isolation.

AB - Pluripotent stem cells possess the capacity for self-renewal and the ability to differentiate into all cell types of the three embryonic germ layers. Accordingly, given their potential use in regenerative medicine, they have long attracted the attention of researchers. Embryonic stem cells (ESCs) represent the model pluripotent stem cell population. However, the use of ESCs in regenerative therapies faces major hurdles-namely, immune rejection and the necessity to use early-stage embryos for ESC isolation.

UR - http://www.scopus.com/inward/record.url?scp=79955466666&partnerID=8YFLogxK

U2 - 10.1038/clpt.2010.341

DO - 10.1038/clpt.2010.341

M3 - Article

C2 - 21389982

AN - SCOPUS:79955466666

SN - 0009-9236

VL - 89

SP - 746

EP - 749

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 5

ER -

Disease correction the iPSC way: Advances in iPSC-based therapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this